SALL4 and acute myeloid leukemia: The median level of SALL4 mRNA expression in patients with acute AML without treatment was 86-fold higher than that in the healthy controls (Z = −6.89, p = 0.001), 38-fold higher than that in the AML CR phase (Z = −6.34, p = 0.001), and 17-fold higher than that in the PR phase (Z = −3.61, p = 0.001).